HOT NEWS
Pfizer and Medivation Announce Results From Two Phase 3 Studies in Dimebon » Pfizer Inc. (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) announced results from two Phase 3 trial...
Nycomed on track in 2009 with strong growth in Key Products » Nycomed was on track in 2009, with strong growth in Key Products and most emerging markets. Pantopra...
Bayer Successful in a Difficult Environment » 2009 was operationally one of the strongest years for the Bayer Group. "We were successful in a diff...
Phase III study of Avastin in advanced stomach cancer did not meet primary endpo... » Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the topline results from a global phase III trial inves...
Sanofi Pasteur's A(H1N1) Vaccine HUMENZA®* Recommended by European Medicines Ag... » Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announc...
FY2009: Merck KGaA Revenues Rise by 2.1% to € 7.7 Billion » Merck KGaA announced that Group total revenues rose 2.1% in 2009 - meeting the guidance given earlie...
GSK receives positive opinions in Europe for Tyverb® and Votrient™ » GlaxoSmithKline (GSK) announced that the European Medicines Agency's Committee for Medicinal Product...
My child matters Supports Seven New Childhood Cancer Care Projects » On the International Childhood Cancer Day, the International Union Against Cancer (UICC) and sanofi-...
Abbott Completes Acquisition of Solvay Pharmaceuticals » Abbott (NYSE: ABT) today announced that it has completed its EUR 4.5 billion ($6.2 billion) acquisit...
Merck Receives European Approval for ELONVA® (corifollitropin alfa injection) » Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European C...
GlaxoSmithKline
GlaxoSmithKline (GSK)GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk.com.

GlaxoSmithKline RSS Channel
Filter     Display # 
# Article Title Hits
1 GSK receives positive opinions in Europe for Tyverb® and Votrient™ 359
2 Government orders for pandemic H1N1 vaccine 346
3 Revolade (eltrombopag) receives positive opinion in Europe for chronic immune thrombocytopenic purpura 547
4 GSK initiates second pivotal Phase III trial for investigational cardiovascular medication Darapladib 617
5 GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine 366
6 Experience of GSK's H1N1 adjuvanted vaccine, Pandemrix™, and preliminary paediatric results 3660
7 Results from second clinical trial of GSK's H1N1 adjuvanted vaccine confirm immune response and tolerability 1192
8 GSK partners with UK Government and Wellcome Trust to stimulate innovation 780
9 Initial results from first clinical trial of GSK's H1N1 adjuvanted vaccine 767
10 Pandemic (H1N1) 2009 influenza update 629
11 Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis 949
12 WHO grants prequalification to Cervarix®: GSK's vaccine to help combat cervical cancer in developing nations 788
13 GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs 526
14 GSK announces a strategic alliance with Dr. Reddy's Laboratories Ltd 925
15 World Health Organization grants Global Prequalification to GSK's Rotarix™ vaccine 569
16 GlaxoSmithKline update: A (H1N1) influenza vaccine development 953
17 GlaxoSmithKline update: influenza A (H1N1) 685
18 Emergence of a new H1N1 influenza A strain (swine influenza) 565
19 OTC weight loss aid is available in pharmacies across Europe 793
20 GSK submits Tyverb®/Tykerb® for first-line treatment of metastatic breast cancer in Europe, US 700
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2
Bookmark and Share

Banner